Corcept Therapeutics Inc. share price logo

Corcept Therapeutics Inc.

NASDAQ: CORT

Large Cap

$108.61

+0.66

(+0.61%)

Live

as on

Corcept Therapeutics Inc. Stock Performance

as on August 8, 2026 at 2:09 am IST

  • Day's Low

    Day's High

    $108.08
    $109.97
    downward going graph

    0.49%

    Downside

    1.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $28.66
    $122.21
    downward going graph

    73.61%

    Downside

    12.52%

    Upside

    downward going graph

Corcept Therapeutics Inc. share price movements today

Previous Close
$107.95
Open
$108.08
Volume
148.8K
Day's Low - High
$108.08 - $109.97
52 Week Low - High
$28.66 - $122.21

Corcept Therapeutics Inc. Historical Returns

1 Month Return
+ 14.79 %
3 Month Return
+ 111.46 %
1 Year Return
+ 51.02 %
3 Year Return
+ 257.1 %
5 Year Return
+ 394.5 %

Corcept Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Corcept Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.0B

EPS (TTM)

2.1333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.24%

PE Ratio (TTM)

245.98

Industry PE ratio

3.374615384615385

PEG Ratio

0.813

EBITDA

8.1M

Revenue (TTM)

830.8M

Profit Margin

6.64%

Return On Equity TTM

8.23%

Corcept Therapeutics Inc. Stock Valuation

Track how Corcept Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Corcept Therapeutics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (18.61x)

December 31, 2021

Industry (3.37x)

August 7, 2026

Today (245.98x)

August 7, 2026

Highest (143.77x)

June 30, 2026

LowHigh

Today’s Price to Earnings Ratio: 245.98x

Corcept Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corcept Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Corcept Therapeutics Inc. image
Corcept Therapeutics Inc.
BUY$12.0B394.5%245.986.64%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$41.9B606.97%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$122.9B141.21%27.8535.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$79.1B26.4%18.8327.87%0.48%

Stock Returns calculator for Corcept Therapeutics Inc. Stock including INR - Dollar returns

The Corcept Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corcept Therapeutics Inc. investment value today

Current value as on today

₹1,64,888

Returns

₹64,888

(+64.89%)

Returns from Corcept Therapeutics Inc. Stock

₹51,945 (+51.94%)

Dollar Impact

₹12,944 (+12.94%)

Analyst Recommendation on Corcept Therapeutics Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Corcept Therapeutics Inc.. Average target price of $135.25

Corcept Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Corcept Therapeutics Inc..

What analysts predicted

19.7%UPSIDE

Target Price

$135.25

Current Price

$108.61

Analyzed by

11 Analysts

Target

$135.25

Corcept Therapeutics Inc. target price $135.25, a slight upside of 19.7% compared to current price of $108.61. According to 11 analysts rating.

Indian Investors' Interest in Corcept Therapeutics Inc. Stock

Investment in Corcept Therapeutics Inc. Shares on INDmoney has grown by 158.49% in the last 30 days, indicating increased investment activity.

Time period: to

Change:158.49% versus previous 30 day period

Search interest for Corcept Therapeutics Inc. Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:133% versus previous 30 day period

Corcept Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
146
163
182
181
157
194
207
202
164
256
Gross Profit
144
161
179
178
154
190
203
199
162
252
Operating Income
29
35
46
25
3
26
10
4
-49
41
EBITDA
35
41
53
32
10
32
15
10
-44
46
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
34
41
52
31
9
31
15
9
-44
45
Income Tax Expense
7
6
5
1
-10
-3
-4
-14
-13
-2
Net Income
27
35
46
30
20
35
19
24
-31
42
Net Profit Margin
18.91%
21.67%
25.58%
16.71%
13.07%
18.08%
9.47%
12.02%
-18.92%
16.45%

Corcept Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
81
159
251
306
353
365
401
482
675
761
Gross Profit
79
155
246
300
348
360
396
475
664
748
Operating Income
10
52
89
111
128
124
112
107
136
44
EBITDA
10
52
89
113
130
127
115
125
162
68
Interest Expense
2
0
2
5
5
3
3
-
-
-
Depreciation
-
0
0
2
2
3
2
2
1
1
Income Before Tax
8
52
92
116
131
125
116
124
161
66
Income Tax Expense
-
-76
16
22
25
12
14
18
20
-33
Net Income
8
129
75
94
106
112
101
106
139
99
Net Profit Margin
10.01%
81.11%
30.01%
30.73%
29.96%
30.74%
25.24%
22.00%
20.70%
13.09%

Corcept Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
35
46
30
20
35
19
98
-31
42
Operating Cash Flow
41
73
59
5
43
54
38
-16
33
Investing Cash Flow
-60
-44
-64
-3
70
14
-11
4
-29
Financing Cash Flow
-2
-21
-4
-39
-102
-46
-31
0
-2
Change in Cash
-21
8
-9
-37
12
22
-4
-11
2

Corcept Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
129
75
94
106
112
101
106
141
98
Operating Cash Flow
60
115
136
151
167
120
127
198
141
Investing Cash Flow
-73
-90
-117
-119
136
-114
90
-177
69
Financing Cash Flow
-7
-14
-28
12
-302
-17
-148
-28
-220
Change in Cash
-20
10
-10
44
1
-11
69
-7
-7

Global Institutional Holdings in Corcept Therapeutics Inc.

Funds
Holdings
Geode Capital Management, LLC
2.51%
AQR Capital Management LLC
0.83%
The Goldman Sachs Group Inc
0.67%
Citadel Advisors Llc
0.8%
Morgan Stanley - Brokerage Accounts
0.94%
See all

Corcept Therapeutics Inc. News & Key Events

  • img

    Today's Timeline - 30 July

    Thu, 12:18 PM

    -

    Corcept Therapeutics reports Q2 earnings of $0.36, beating estimates, and raises 2026 revenue guidance to $1.1-$1.2 billion.

    Thu, 09:32 PM

    -

    Corcept's stock soars 22% after hours following strong Q2 results and raised revenue guidance.

Insights on Corcept Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CORT stock has moved up by 111.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 164.90M → 256.14M (in $), with an average increase of 35.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -31.20M → 42.14M (in $), with an average increase of 174.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 415.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 567.4% return, outperforming this stock by 310.3%

About Corcept Therapeutics Inc.

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
OrganisationCorcept Therapeutics Inc.
Headquarters101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEODr. Joseph K. Belanoff M.D.
E-voting on sharesClick here to vote

Key Management of Corcept Therapeutics Inc.

Name

Title

Dr. Hazel Hunt Ph.D.

Chief Scientific Officer

Mr. Gary Charles Robb J.D.

Chief Business Officer & Secretary

Mr. Atabak Mokari

CFO & Treasurer

Mr. Sean Maduck

President of Endocrinology

Dr. William Guyer Pharm.D.

Chief Development Officer

Mr. Joseph Douglas Lyon

Chief Technology & Accounting Officer

Ms. Amy Flood

Chief Human Resources & Communications Officer

Ms. Monica Tellado

President of Emerging Markets

Mr. Roberto W. Vieira

President of Oncology

Dr. Joseph K. Belanoff M.D.

Co-Founder, President, CEO & Director

FAQs

What is Corcept Therapeutics Inc. share price today?

Corcept Therapeutics Inc. share price today is $108.61 as on . Corcept Therapeutics Inc. share today touched a day high of $109.97 and a low of $108.08.

What is the 52 week high and 52 week low for Corcept Therapeutics Inc. share?

Corcept Therapeutics Inc. share touched a 52 week high of $122.21 on and a 52 week low of $28.66 on . Corcept Therapeutics Inc. stock price today i.e. is trending at $108.61,which is 11.13% down from its 52 week high and 278.96% up from its 52 week low.

What is Corcept Therapeutics Inc.'s market capitalisation today?

Corcept Therapeutics Inc. market capitalisation is $0.01T as on .

How to invest in Corcept Therapeutics Inc. Stock (CORT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Corcept Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corcept Therapeutics Inc. Shares that will get you 0.0138 shares as per Corcept Therapeutics Inc. share price of $108.61 per share as on August 7, 2026 at 8:39 pm IST.

What is the minimum amount required to buy Corcept Therapeutics Inc. Stock (CORT) from India?

Indian investors can start investing in Corcept Therapeutics Inc. (CORT) shares with as little as ₹95.198 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.98 in Corcept Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Corcept Therapeutics Inc. share’s latest price of $108.61 as on August 7, 2026 at 8:39 pm IST, you will get 0.0921 shares of Corcept Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Corcept Therapeutics Inc. has given to Indian investors in the last 5 years?

Corcept Therapeutics Inc. stock has given 394.5% share price returns and 28.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?